This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Martin Ian Smith: Innovator in Neuropeptide Receptor Research
Introduction
Martin Ian Smith is a notable inventor based in Enfield, GB. He has made significant contributions to the field of neuropeptide receptor research. His innovative work has led to advancements in methods for diagnosing and treating diseases related to the HFGAN72 receptor.
Latest Patents
Martin Ian Smith holds 1 patent for his invention titled "Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72." This patent includes polypeptides of HFGAN72 receptor ligands and polynucleotides encoding these polypeptides. The methods described in the patent aim to diagnose or treat diseases associated with the under- or over-expression of HFGAN72 receptor ligands. Additionally, the patent outlines methods for identifying agonists or antagonists of the interaction between HFGAN72 receptor ligands and the HFGAN72 receptor. It further discloses treatment methods by administering the identified agonists or antagonists to patients in need.
Career Highlights
Martin Ian Smith is associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of neuropeptide receptors and their implications in medical treatments.
Collaborations
Some of his notable coworkers include Neil Upton and James Joseph Hagan. Their collaborative efforts have further enhanced the research and development in the field of neuropeptide receptors.
Conclusion
Martin Ian Smith's innovative contributions to neuropeptide receptor research exemplify the impact of dedicated inventors in the medical field. His patent work continues to pave the way for new treatment methodologies.